| | | 20,000+ Fresh Resumes Monthly | |
|
|
| |
Click here or scroll down to respond to this candidateCandidate's Name , Ph.D., RN.Street Address .PHONE NUMBER AVAILABLE (Cell)E-mail: EMAIL AVAILABLECLINICAL NURSING EXPERIENCEChildrens National Medical Center, Washington, DC. July 9, 2012 to Present.Community Health Nurse (RN) School Services. Independent evidence-base practice of the provision of clinical nursing services in the District of Columbia Public and Chartered Schools. Managed the school program via commitment to achieving organizational success, children safety in the schools, to the families of students, faculty, staff and colleagues. Forward thinking, teamwork, quality of care, health education, work ethic, integrity, customer service, are co-values of clinical excellence.National Lutheran Community (The Village), Rockville, MD. July 2011 to July 2012.Charge Nurse, RN: Managed, supervised and provided clinical nursing services associated with, admission of clients for rehabilitation services, discharges to home care, intravenous infusions, wound care, blood draw, educated and trained other staff on clinical skills. Assessed patients, developed plan of care, coordinated patient care with the patients family, physician and other healthcare team of diverse disciplines; referred patients to community social workers, physical therapy, occupational therapy and speech therapy; evaluated and sent to the hospital critical and emergency care patients.Health Management Inc. 1025 Vermont ave. Washington, DC. October 2010 to Feb.2013.RN Home Healthcare Supervisor/Case Management.Supervised RNs, LPNs, HHAs, PCAs, and provided clinical nursing skilled care at home for Medicaid, Medicare and private pay admissions. Provided skilled nursing services such as OASIS, intravenous infusions, wound care, blood draw/phlebotomy services, educated and trained other staff on clinical skills. Assessed patients, developed plan of care, coordinated patient care with the patients family, physician and other healthcare team of diverse disciplines; referred patients to community social workers, physical therapy, occupational therapy and speech therapy; evaluated and sent to the hospital critical and emergency care patients, Case Management services such as admitted patients into the Medicaid Waiver program, referred patient to community care services.J.D. Nursing & Management Services, Inc. 7826 Eastern Avenue, Washington, DC. January 2007 to October 2010.Director of Nursing & Clinical EducationProvided leadership and technical support in the development of policies and procedures in the planning, operation and implementation of the home healthcare delivery process in conformity with the regulatory affairs of the department of health and human services.Directed, managed, educated, trained, supervised all employees and monitored daily, the quality assurance of home healthcare services provided to our customers.Provided hands-on training in clinical and out-come assessments and monitoring of patients affected with diverse chronic and acute disease conditions.Conducted site visits for skilled nursing, physical therapy, respiratory therapy, occupational therapy, home health aide, social worker, speech therapy and patient education.Provided quality assurance to validate the proficiency, efficacy, compliance and accountability of services provided to our clients.Provided leadership in the organization, supervision and technical assistance in the successful surveying and licensing of the organization for Medicare and Medicaid services.Provided technical assistance in conducting in-services for all employees on advanced techniques, equipment and other medical devices in the health care, industry.Conducted clinical research on patients to determine the effect of moderate and heavy alcoholic consumption as related to cardiac disease.Conducted Case Management services for patients in the EPD waiver program and applied for EPD waiver programs for patients who are qualified.Contracted with Hospital for Sick Children to provide pediatric care to patients with multiple health issues. Supervised the nurses taking care of these sick children, including the home health aides.Experienced in Medicare, Medicaid and Medicaid Waiver management.Premium Select Home Care Inc., 5513 Illinois Ave. NW Washington, DC. December 2010 to July 2012.RN Supervisor/Case ManagementSupervised RNs, LPNs, HHAs, PCAs, and provided clinical nursing skilled care at home for Medicaid, Medicare and private pay admissions. Provided skilled nursing services such as OASIS, intravenous infusions, wound care, blood draw/phlebotomy services, educated and trained other staff on clinical skills. Assessed patients, developed plan of care, coordinated patient care with the patients family, physician and other healthcare team of diverse disciplines; referred patients to community social workers, physical therapy, occupational therapy and speech therapy; evaluated and sent to the hospital critical and emergency care patients, Case Management services such as admitted patients into the Medicaid Waiver program, referred patient to community care services.Providence Hospital, 1150 Varnum Street, Washington DC. June 2004 to July 2007.Registered Nurse (Specialist).Managed and provided clinical nursing services associated with, emergency care, critical care unit, coronary care unit, surgical recovery, telemetry, clinical oncology, step-down.Performed clinical research to evaluate the effect of moderate and heavy consumption of alcohol on the human heart.Precepted Nursing Students in clinical nursing practice.Saint Elizabeth Hospital, Washington DC. (SAR) August 2007 to August 2009.Registered Nurse (Psychiatry)Managed and supervised nurses and technicians, provided clinical nursing services associated with psychotic disorders, substance abuse. Collected forensic data from patients (under court order) for analysis for the justice department.Dewitt Army Hospital, Farrell Street, Fort Belvoir, VA. May 2006 October 2006.Registered Nurse (Same Day Surgery, PACU/GI).Provided and administered anesthetic and analgesic drugs to patients undergoing endoscopic and colonoscope procedures for diagnostic and therapeutic purpose.Performed pre-operative teaching instructions to patient undergoing diverse procedures.Performed EKG, venipuncture and monitored patients on cardiac monitors during operative procedures.Managed and supervised other nurses.Manor Care Inc., Silver Spring, MD. 2004 - 2005.Assistant Director of Nursing.Managed, supervised and monitored daily, the quality of healthcare services provided to our customers.Managed patients with neurological disabilities, such as head trauma injuries that resulted in paralysis, spinal bifida patients.Assisted and coordinated clinical studies in neurological patients.Scheduled Nurses and other healthcare providers, for their daily work-schedules.Monitored documentation of data collection, treatments and responses.Prince Georges Hospital Center, Cheverly, MD, April 2004 to June 2004.Assistant Manager (RN).Managed, supervised and monitored daily the quality of healthcare services provided to our customers.Scheduled nurses and other healthcare employees for their daily work-schedules.Monitored research activities that promoted patient care and outcome of treatment.Washington Hospital Center, Washington, D.C. February 2003 to February 2004Registered Nurse (Specialist)Provided clinical nursing services associated with critical care unit (ICU), clinical oncology, and step-down.Howard University Hospital, Washington, DC. 1993 1996.Registered NurseManaged, supervised nurses and provided hands-on clinical nursing services in diverse therapeutic indications, associated with emergency, telemetry, medical intensive care unit, step-down, psychiatry, transplant surgery, preoperative evaluation, surgical recovery, walk-in clinic and med/surg.Performed venipunctures, intravenous infusions and transfusions.Monitored patients on ventilators, cardiac monitors and other types of machines, including medication administrations.UNIT DIRECTOR OF NURSING (RN)Provided leadership in the planning, organizing and management of the unit for trauma and major surgical procedures.Provided public health training in the rural localities in maternal and child health.Conducted seminars and educated the local communities on hygiene, child nutrition, breastfeeding and family planning.Consulted, triaged, performed minor surgery, delivered babies, supervised and managed other nurses.Treated children and adult patients infected with malaria and other tropical diseases.CLINICAL RESEARCH SCIENTISTOver 30 years experience of increasingly responsible diverse clinical and basic research (under GCP, GLP) on infectious diseases, immunology, oncology, pharmacology, pharmacokinetics, toxicology and regulatory affairs. Participated, drafted, reviewed and submitted INDA/NDA to FDA. Served as resource person, or acquired and maintained technical authority; proven ability in using research findings to make recommendations and decisions on specific therapeutic regimen. Established relationships with key opinion leaders in the pharmaceutical industry on innovative technologies in drug development; initiated studies, developed, validated, quantitated new diagnostic assays for medical devices and pathogenic micro-organisms. Drafted technical test protocols and standard operating procedures (SOPs), which increased productivity by six-fold. Collaborated and networked with national, regional and local opinion leaders. Track record of ability to plan, organize direct and coordinate research projects; analyzed preclinical and clinical data, approved test results, wrote reports, made presentations at business meetings and seminars. Solid skills in technical writing, publication and presentation. Correlated in vitro drug results with clinical response. Analyzed pharmacokinetics/pharmacodynamics of novel anti-cancer agents to impact decision on patient treatment protocols. Managed clinical data utilizing SAS program for analysis, writing reports and published data.Relevant Practical Experience in two continents: Africa and North America;Fluency: English FrenchEDUCATION AND TRAININGPostdoctoral Fellowship Lombardi Cancer Center, Georgetown University Medical Center, Washington, DC 1992 - 1996North Carolina State University, Raleigh, North Carolina 1990. Ph.D. Immunology/Pharmacology.North Carolina Central University, Durham, North Carolina 1985. M.S. Biology/Microbiology.Gardner Webb College, Boiling Spring, North Carolina 1981. B.S. Biology/Chemistry/Mathematics.Nursing School Bamenda, Cameroon. 1974. Registered Nurse (RN).OTHER ADVANCED TRAININGNational Institutes of Health, Bethesda, Maryland 1997-1998. Clinical Pharmacokinetics, Post-Graduate Certificate Program, FAES.National Institutes of Health, Bethesda, Maryland 1998-1999. Principle and Practice of Clinical Research, Post-Graduate Certificate Program.PROFESSIONAL RESEARCH EXPERIENCEHoward University, Department of Pharmaceutics, Allied Health & Nursing, Washington, DC. January 2003 to 2009.Professor & Clinical Specialist.Coordinated, directed and trained postdoctoral fellows on research projects; conducted and coordinated clinical rotations with nursing students, developed and taught patient plan of care, research and Patho-physiology.Provided leadership in setting up an in vitro tissue culture laboratory for the evaluation of anticancer drug.Mary Babb Randolph Cancer Center, West Virginia University, Morgantown, WV. January 2001 to 2005.Research ScientistProvided technical assistance on the planning, organizing and the conduction of research projects.Evaluated the effect of antineoplastic agent, harringtonine, on cisplatin sensitivity and the reduction of DNA repair capacity through p53 pathway; analyzed and published the data.National Cancer Institute, National Institutes of Health, Bethesda, MD January 1997 to January 2001.Research ScientistManaged and supervised the laboratory activities of 5 postdoctoral fellows from three international countries involved in HIV-AIDS clinical trials, particularly, children and in cancer research resulting in several publications.Evaluated the clinical pharmacokinetics /pharmacodynamics of novel anti-cancer and correlated disease response in patients.Measured platinum-DNA adducts in patient samples, animal tissues, and tissue culture materials by routinely applying atomic absorption spectrometry techniques to quantitate the DNA-adduct levels and determined the clinical response in patients.Evaluated sub cellular pharmacology of novel metal-based anti-cancer agents in combination with other drugs to assess for synergy in treating ovarian cancer.Investigated the potential of nucleosome as novel target for cancer chemotherapy resulting in three publications.Lombardi Cancer Center, Georgetown University Medical Center, Washington, D.C. December 1992 to December 1996.Postdoctoral FellowTargeted angiogenesis in breast cancer with combinations of anti-angiogenic agents using immunohistochemistry resulting in three publications.Evaluated the clinical pharmacokinetics/pharmacodynamics of novel anti-cancer agents in breast cancer patients to impact decision on patient treatment protocols.Developed and introduced an in vivo experimental model for drug clinical trials.Evaluated in vitro and in vivo novel anti-cancer drugs.Performed the clinical pharmacokinetics and conducted the mechanisms of drug action used in clinical trials.Developed a heparin-binding growth factor assay, which was used in screening basic FGF in urine and serum samples of patients in clinical trials resulting in publication of the article in a clinical research journal.Becton Dickinson Research Center Research Triangle Park, North Carolina 1989 - 1992.Toxicologist/Study DirectorProvided leadership on the planning, organizing, designing and directed technical toxicological testing, in vitro and animal models, of medical devices, which increased productivity by six-fold.Conducted preclinical evaluations of medical devices and other therapeutic regimen.Developed new test protocols and Standard Operating Procedures (SOPs) according to Food and Drug Administration (FDA) and United States Pharmacopoeia (USP) guidelines.Developed a quantitative and automated test for bacterial endotoxins and performed the test on medical devices.Trained, supervised and certified all staff to perform newly developed tests.PUBLICATIONS1.Candidate's Name , Laura Bush (US First Lady), Timothy Ziemer and Emmanuel Okocha. Laura Bush takes the offensive against malaria, in, America mi Dream, vol. 1: p. 10-11, 13., 2007.2.Yunmbam MK, Guo Y, Miller MR and Yu JJ. Combinatorial treatment of ovarian cancer cells with harringtonine and cisplatin results in increased cisplatin-DNA adducts., Oncology Reports, 11(4):PHONE NUMBER AVAILABLE3.Yunmbam, M.K., and A. Wellstein. The bacterial polysaccharide tecogalan blocks growth of breast cancer cells in vivo, Oncology Reports, 8(1):PHONE NUMBER AVAILABLE4.Qingdi Li, Candidate's Name , Edward G. Mimnaugh, Len Neckers, and Eddie Reed. Lactacystin Enhances Cisplatin Sensitivity in Resistant Human Ovarian Cancer Cell Lines via Inhibition of DNA Repair and ERCC-1 statement. Cellular and Molecular Biology, 47 (9): 61-72, 2001.5.Candidate's Name , Qingdi Li, Edward G. Mimnaugh, Ganesh L. Kayastha, Len Neckers, and Eddie Reed. Effect of the proteasome inhibitor ALLnL on cisplatin sensitivity in human ovarian cancer cells. . Intl. J. Oncology, 19: PHONE NUMBER AVAILABLE6.Mimnaugh, E.G., Yunmbam, M.K., Li, Q., Bonvini, P., Hwang, S.G., Nguyen, P., Trepel, J., Reed, E., and Neckers, L. Proteasome inhibitor-promoted nucleosomal histone deubiquitination blocks repair of cisplatin-DNA adducts in ovarian carcinoma cells. Biochemical Pharmacology, 60(9):1343-1354, 2000.7.Qingdi Li, Jing Jie Yu, Chuanjie Mu, Candidate's Name , Daniel Slavsky, Cheryl L. Cross, Frieda Bostick-Bruton, and Eddie Reed. 2000. Association between the Level of ERCC-1 statement and the Repair of Cisplatin-Induced DNA Damage in Human Ovarian Cancer Cells. Anticancer Research, 20:PHONE NUMBER AVAILABLE8.Yunmbam, M.K. Inhibition of breast cancer in nude mouse by anti-angiogenesis. Oncology Reports 5:1431-1437, 1998.9.Marshall JL; Wellstein A; Rae J; DeLap RJ; Phipps K; Hanfelt J; Yunmbam MK; Sun JX; Hawkins MJ. Phase I trial of orally administered pentosan polysulfate in patients with advanced cancer. Clinical Cancer Research, 1997 Dec; 3(12 Pt 1):2347-54.10.Yunmbam, M.K. and J.F. Roberts. 1993. Evaluation of reuterin and its combinations with suramin, melarsoprol, DL-a-Difluoromethylornithine and bleomycin in mice infected with Trypanosoma brucei brucei. Comparative Biochemistry and Physiology 105C:521-524.11.Yunmbam, M.K. and J.F. Roberts. 1992. The in vitro efficacy of reuterin on the culture and bloodstream forms of Trypanosoma brucei brucei. Comparative Biochemistry and Physiology 101C:235-238.12.Candidate's Name . The effect of a newly discovered antimicrobial substance reuterin, against Trypanosoma brucei brucei, Doctoral Thesis. North Carolina State University, Raleigh, NC., December 1989.13.Padilla, G.M., M. K. Yunmbam, G.L. Whitson and V.P. Petrow. In Vitro inhibition of cell proliferation and protein kinase activity of Dunning AT3 rat prostate tumor cells. Cell Tissue Kinetics 21, 205-212. The Twelfth Biennial Conference of the International Cell Cycle Society; St. Petersburg, Florida, 20-23 April 1988.14.Candidate's Name , Ph.D., Yi Guo, B.S., Eddie Reed, M.D., Michael R. Miller, Ph.D. Jing Jie Yu, M.D. Antineoplastic Agent Harringtonine Increases Cisplatin DNA Adduct and Alters p53 Expression in Ovarian Cancer Cells.15.Yunmbam MK, Guo Y, Reed E, Miller MR and Yu JJ. The antineoplastic product harringtonine increases cisplatin-DNA adducts and alters p53 expression in ovarian cancer cells. (abstract) Proc Am Assoc Cancer Res, 44 (2nd dition):abst # R4040, 2003.ABSTRACTS16.Mimnaugh, E.G., Yunmbam, M.K., Li, Q., Reed, E., and Neckers, L. 1997. Blocked repair of cisplatin-induced DNA damage and increased cisplatin cytotoxicity associated with nucleosomal histone deubiquitination. AARC Annual Meeting, March 28-April 1, 1998, New Orleans, LA.17.Reed, E., Dabholkar, M., Yunmbam, M.K., and Jones, L. 1997. Platinum-DNA adduct in vitro and in the clinic. AARC Annual Meeting, March 28-April 1, 1998, New Orleans, LA.18.E.G. Mimnaugh, M.K. Yunmbam, Q. Li, J. Trepel, E. Reed, and L. M. Neckers. 1998. Proteasome inhibition induces nucleosomal histone deubiquitination, inhibits the repair of cisplatin-induced DNA damage, and augments cisplatin-dependent cytotoxicity. Submitted: First Annual Meeting on the Experimental Therapeutics of Human Cancer, June 11-13, 1998, Hood College, Frederick, MD.19.E.G. Mimnaugh, M.K. Yunmbam, Q. Li, E. Reed, P. Bonvini, S.G. Hwang, J. Trepel, L. Neckers. 1998. Nucleosomal Histone Deubiquitination in DNA Nucleotide Excision Repair and Apoptosis. NIH Research Festival, October 6-9, 1998.20.Yunmbam, M.K., E Mimnaugh, L Neckers, F Bostick-Bruton, and E Reed. Effects of two proteasome inhibitors on cisplatin sensitivity in human ovarian cancer cells. AARC Annual Meeting, April 1-5, 2000, San Francisco, CA.21.F Ponce, M Yunmbam, M Simpson, F Bostick-Bruton, and E Reed. Increased sensitivity of a physical chemistry method for detecting heavy metals in biological matrices. AARC Annual Meeting, April 1-5, 2000, San Francisco, CA. |
